Fungal Infection

Posaconazole Pharmacokinetics in Patients Receiving Chemotherapy or Stem Cell Transplants

Dosing Obese With Noxafil® Under a Trial (DONUT)

Posaconazole as Salvage Therapy for Aspergillus Pulmonary Infection.

A Pharmacokinetic Analysis of Posaconazole in Lung Transplant Recipients (MK-5592-105)

Efficacy and Safety of Caspofungin for Invasive Pulmonary Aspergillosis Underlying Chronic Obstructive Pulmonary Disease

Oral Posaconazole in High Risk Patients With Gastrointestinal Dysfunction (Study P05115)

Randomized Study of Caspofungin Prophylaxis Followed by Pre-emptive Therapy for Invasive Candidiasis in the Intensive Care Unit (ICU)

ProphyALL - Study on the Safety of Liposomal Amphotericin B to Prevent Antifungal Infections in Elderly Patients With Acute Lymphoblastic Leukemia

Assessing the Safety and Efficacy of MK-5592 (Posaconazole) in Japanese Participants With Fungal Infection (MK-5592-101)

Safety and Efficacy Study of Posaconazole vs. Fluconazole for Prevention of Invasive Fungal Infection (P05387 AM1)(COMPLETED)

Posaconazole Treatment of Invasive Fungal Infection (IFI) (P05551)

A Clinical Study of MK0991 (Caspofungin) in Japanese Patients With Deep-seated Candida or Aspergillus Infections (0991-062)(COMPLETED)

A Study of Caspofungin Acetate (MK0991) for the Treatment of Esophageal Candidiasis or Invasive Candidiasis in Chinese Adults (MK-0991-066)

POS vs FLU for First Line Treatment of Coccidioidomycosis (Study P04558Am1)(COMPLETED)

Evaluate the Safety and Efficacy of Caspofungin Acetate as Empirical Therapy in Chinese Adults With Persistent Fever and Neutropenia (0991-055)

A Multicenter, Randomized, Double-Blind, Comparative Study to Evaluate the Safety, Tolerability, and Efficacy of 2 Dosing Regimens of an Antifungal Drug in the Treatment of Fungal Infections in Adults (0991-801)(COMPLETED)

A 28 - 90 Days Study to Evaluate the Safety, Tolerability, and Efficacy of Caspofungin Injection as Empirical Therapy in Indian Adults With Persistent Fever and Neutropenia (0991-053)(COMPLETED)

Prophylaxis Trial of Posaconazole Versus Standard Azole Therapy for Neutropenic Patients (Study P01899)

Study of Posaconazole in the Treatment of Invasive Fungal Infections (Study P02095)

Prophylaxis Trial in High Risk Allogenic Stem Cell Transplant Recipients With Graft vs. Host Disease

Open Label Study of Posaconazole in the Treatment of Invasive Fungal Infections (Study P00041)

Universal Prophylaxis Versus Pre-emptive Therapy With Posaconazole Post-Lung Transplant

Posaconazole Prophylaxis During ATG Treatment for hMDS/AA Patients

Safety, Tolerability, and Efficacy of Caspofungin Versus Amphotericin B Deoxycholate in the Treatment of Invasive Candidiasis in Neonates and Infants (MK-0991-064)

Pharmacokinetic, Safety and Efficacy of Intermittent Application of Caspofungin for Antifungal Prophylaxis

A Study of Caspofungin (MK-0991) in Japanese Children and Adolescents With Documented Candida or Aspergillus Infections (MK-0991-074)

Caspofungin as Prophylaxis in High Risk Liver Transplantation Recipients

A Study to Examine the Efficacy and Safety of Posaconazole When Introduced Early in the Treatment of Refractory Fungal Infections (P05090 AM2)

Intermittent Liposomal Amphotericin B Primary Prophylaxis

Open, Pharmacokinetic Study of Caspofungin in Neonates and Infants (0991-058)

Open, Pharmacokinetic Study of Caspofungin Acetate in Immunocompromised Young Children With Febrile Neutropenia (0991-042)

Caspofungin for the Treatment of Non-blood Candida Infections (0991-045)

Documented Candida or Aspergillus Infections in Pediatric Patients (0991-043)

Prophylaxis With Caspofungin in High-Risk Liver Transplantation

MK0991 in Combination With Standard Antifungal Agent(s) for the Treatment of Salvage Invasive Aspergillosis (0991-037)

PK/PD Study of Posaconazole for Empiric Treatment of Invasive Fungal Infections in Neutropenic Patients or Treatment of Refractory Invasive Fungal Infections (Study P01893)

Safety of hLF1-11 for the Treatment of Infectious Complications Among HSCT Recipients

ADME Study of [14C]-Ibrexafungerp in Healthy Male Subjects

A Drug-Drug Interaction Study of CYP3A4 Inhibition and Pan-CYP Induction on APX001

A Study to Assess the Mass Balance Recovery and Metabolite Profile & Identification of [14C]-APX001 in Healthy Males

Pharmacokinetics and Safety of Intravenous Posaconazole (MK-5592) in Chinese Participants at High Risk for Invasive Fungal Infections (MK-5592-120)

Safety, Pharmacokinetics, Bioavailability, Food Effect, Drug-Drug Interaction Study of APX001 Administered Orally

Study to Assess Safety, Tolerability and Pharmacokinetics of APX001 Administered by Intravenous Infusion to Healthy Subjects

Pharmacokinetics and Safety of Oral Posaconazole (MK-5592)Tablets in Chinese Participants at High Risk for Invasive Fungal Infections (MK-5592-117)

Pharmacokinetics and Safety of Posaconazole Tablet in Participants at High Risk for Invasive Fungal Infections (MK-5592-065/P05615)

A Study of the Safety, Tolerance, and Pharmacokinetics of Oral Posaconazole in Immunocompromised Children (P03579)

Alternate Day Micafungin: A PK Study in Pediatric Patients

Single Patient Treatment of Posaconazole in Invasive Fungal Infections (Study P05113)

An Open-label Study Evaluating the Effectiveness of CGB-400 Topical Gel for Fungal Infection

Posaconazole Prophylaxis for CAPA Prevention in Critically-Ill Patients